Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Xanthopoulos Kleanthis G
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   122,200    

Indirect Shares

   281,935      
Direct Value   $19,622    

Indirect Value

   $164,649      
Total Shares   404,135      
Total Value   $184,270      


Anadys Pharmaceuticals Inc $0 Seelos Therapeutics Inc $9,301 Regulus Therapeutics Inc. $7,484 Zosano Pharma Corp $2,836 Anadys Pharmaceuticals Inc $0 Seelos Therapeutics Inc $9,301 Regulus Therapeutics Inc. $7,484 Zosano Pharma Corp $2,836
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Anadys Pharmaceuticals Inc ANDS Director 2007-08-16 7,399 2007-08-16 177,144    Premium*  
            Seelos Therapeutics Inc SEEL Director 2012-08-15 87,500 2017-01-05 24,575    Premium*  
            Regulus Therapeutics Inc. RGLS President and CEO, Dir... 2015-04-21 3,705 2015-04-21 80,216    Premium*  
            Zosano Pharma Corp ZSAN Director 2021-06-10 23,596 2015-04-01 0    Premium*  
* Premium Members only  

Records found :    89         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ANDS Anadys Pharmaceuticals In... CEO and PresidentOfficer   •       •      –    2004-03-18 3 IO $0.00 $0 I/I 0 244,885 -
RGLS Regulus Therapeutics Inc. President & CEOOfficer   •       •      –    2012-10-04 3 IO $0.00 $0 I/I 0 82,216 -
ANDS Anadys Pharmaceuticals In... Director   –       •      –    2007-02-05 4 GD $0.00 $0 I/I 5,000 170,644 0 -
SEEL Seelos Therapeutics Inc Director   –       •      –    2011-11-17 4 A $0.00 $0 D/D 100,000 100,000 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2013-12-16 4 GD $0.00 $0 I/I 2,000 80,216 0 -
ZSAN Zosano Pharma Corp Director   –       •      –    2015-04-01 4 A $0.00 $0 D/D 6,000 6,000 0 -
SEEL Seelos Therapeutics Inc Director   –       •      –    2017-01-05 4 A $0.00 $0 I/I 15,000 24,575 0 -
ZSAN Zosano Pharma Corp Director   –       •      –    2021-06-10 4 A $0.00 $0 D/D 15,000 23,596 0 -
SEEL Seelos Therapeutics Inc Director   –       •      –    2016-09-30 4 A $0.34 $5,750 I/I 16,997 95,746 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-01-02 4 OE $0.38 $1,332 I/I 3,505 83,721 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-02-05 4 OE $0.38 $1,332 I/I 3,505 83,721 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-03-06 4 OE $0.38 $1,332 I/I 3,505 83,721 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-05-27 4 OE $0.38 $662 D/D 1,743 1,743 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-05-28 4 OE $0.38 $333 D/D 875 875 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-05-29 4 OE $0.38 $337 D/D 887 887 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-06-09 4 OE $0.38 $1,332 D/D 3,505 3,505 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-07-01 4 OE $0.38 $1,332 D/D 3,505 3,505 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-08-05 4 OE $0.38 $1,332 D/D 3,505 3,505 0 -
RGLS Regulus Therapeutics Inc. President & CEO   •       •      –    2014-08-28 4 OE $0.38 $1,332 D/D 3,505 3,505 0 -
RGLS Regulus Therapeutics Inc. President and CEO   •       •      –    2014-09-30 4 OE $0.38 $874 D/D 2,300 4,766 0 -
RGLS Regulus Therapeutics Inc. President and CEO   •       •      –    2014-10-09 4 OE $0.38 $40 D/D 105 2,571 0 -
RGLS Regulus Therapeutics Inc. President and CEO   •       •      –    2014-10-14 4 OE $0.38 $152 D/D 400 2,866 0 -
RGLS Regulus Therapeutics Inc. President and CEO   •       •      –    2014-10-17 4 OE $0.38 $152 D/D 400 2,866 0 -
RGLS Regulus Therapeutics Inc. President and CEO   •       •      –    2014-10-20 4 OE $0.38 $114 D/D 300 2,766 0 -
RGLS Regulus Therapeutics Inc. President and CEO   •       •      –    2014-10-29 4 OE $0.38 $1,332 D/D 3,505 5,971 0 -
  89  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us